Healthcare

Healthcare

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

June 25, 2025 admin Comments Off on Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

*Hoth Therapeutics and Silo Pharma Launch Joint Venture to Commercialize VA-Invented Obesity Drug Targeting $100B+ Global Market Exclusive License from U.S. Department of Veterans Affairs to Advance GDNF-Based Therapy for Obesity and Fatty Liver Disease […]

Healthcare

Hoth Therapeutics (NASDAQ: HOTH) Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases

June 12, 2025 admin Comments Off on Hoth Therapeutics (NASDAQ: HOTH) Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases

Protection through 2039, ensuring long-term commercial exclusivity. NEW YORK, June 12, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained Japan Country Patent No. 7677628 […]

Healthcare

Hoth Therapeutics (NASDAQ: HOTH) Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities

June 11, 2025 admin Comments Off on Hoth Therapeutics (NASDAQ: HOTH) Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities

Premier Research to support submission of an Expanded Access Program (EAP) application. This move positions Hoth to offer compassionate access to HT-001 for cancer patients suffering from painful and debilitating skin toxicities caused by epidermal […]

Healthcare

Galmed (NASDAQ: GLMD) Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation

April 28, 2025 admin Comments Off on Galmed (NASDAQ: GLMD) Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation

The proprietary Self-Emulsifying Drug Delivery System (SEDDS) formulation in form of orally dispersible films allows absorption of sublingually administrated peptides such as GLP-1 (Semaglutide, Liraglutide etc.). The new formulation is expected to offer alternatives to both approved […]

Healthcare

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

April 9, 2025 admin Comments Off on Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Successful robotic navigation was achieved in every case and met the primary endpoint of the study LIBERTY® showed a 92% reduction in radiation exposure with no adverse events reported HINGHAM, Mass., April 09, 2025 — Microbot Medical […]

Healthcare

AI/ML Innovations (OTC: AIMLF) Subsidiary Chosen as the Digital Technology Provider for an International Clinical Study Funded by European Commission

October 18, 2023 admin Comments Off on AI/ML Innovations (OTC: AIMLF) Subsidiary Chosen as the Digital Technology Provider for an International Clinical Study Funded by European Commission

Highlights: AI/ML’s subsidiary, Tech2heal, expands its global footprint with second clinical trial contract – conducted jointly by French and Italian University Hospitals. The clinical trial is funded by a European Commission fund. The study includes […]

Healthcare

AI/ML Innovations (OTC: AIMLF) Subsidiary Receives Funding Grant for Its Participation in Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly

October 5, 2023 admin Comments Off on AI/ML Innovations (OTC: AIMLF) Subsidiary Receives Funding Grant for Its Participation in Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly

Highlights: The clinical study, led by the University Hospital of Nice, France involves 30,000 patients. AI/ML Innovations’ subsidiary, Tech2Heal, has been chosen to provide the “technological backbone” for the study. Tech2heal has been awarded a […]

Healthcare

Nova Mentis (OTC: NMLSF) to Enter mRNA AI Diagnostics Business

April 27, 2023 admin Comments Off on Nova Mentis (OTC: NMLSF) to Enter mRNA AI Diagnostics Business

Vancouver, British Columbia–April 26, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]

Healthcare

Nova Mentis (OTC: NMLSF) Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial

April 18, 2023 admin Comments Off on Nova Mentis (OTC: NMLSF) Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial

Vancouver, British Columbia– – April 18, 2023- Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for […]

Healthcare

Nova Mentis (OTC: NMLSF) Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial

April 11, 2023 admin Comments Off on Nova Mentis (OTC: NMLSF) Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial

Vancouver, British Columbia– April 11, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for […]

Healthcare

AI/ML Innovations (OTC: AIMLF) Introduces “Health Coach” – a Personalized AI-powered Health Advisor

April 11, 2023 admin Comments Off on AI/ML Innovations (OTC: AIMLF) Introduces “Health Coach” – a Personalized AI-powered Health Advisor

Health Coach has functionality similar to ChatGPT, but is designed to monitor and manage the users health. Health Coach provides conversational personal health goal setting and care recommendations by directly accessing and utilizing a user’s […]

Healthcare

Nova Mentis (OTC: NMLSF) Provides Corporate Update and 2023 Outlook

April 5, 2023 admin Comments Off on Nova Mentis (OTC: NMLSF) Provides Corporate Update and 2023 Outlook

Vancouver, British Columbia— April 5, 2023- Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]

Healthcare

Increasing Autism Rates Put Spotlight on Potential for Nova Mentis (OTC: NMLSF) Novel Psilocybin Therapeutics

March 29, 2023 admin Comments Off on Increasing Autism Rates Put Spotlight on Potential for Nova Mentis (OTC: NMLSF) Novel Psilocybin Therapeutics

Vancouver, British Columbia–March 29, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]